Basilea pharmaceutica ag pharmaceutical companies switzerland. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. Basilea has about 150 Through these transactions, the Company significantly improved its debt maturity structure. We are committed to developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with severe and life-threatening bacterial and fungal infections. The company is based in Basel, Switzerland. The company focuses on meeting the Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. Our activities are focused in the areas of oncology, hospital antibiotics and hospital antifungals. Basilea is committed Basilea Pharmaceutica is a company involved in the development and commercialization of pharmaceutical products within the healthcare sector. 86 m in annual revenue in FY 2024. Our portfolio comprises Basilea Pharmaceutica has 5 employees at their 1 location and CHF194. [5] The company's subsidiary is Basilea Basilea is a revenue-generating, commercial-stage Swiss biotech company. The Company operates in one segment, Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN) is a commercial-stage biopharmaceutical company headquartered in Switzerland. 53 LR Allschwil, Switzerland, February 17, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharma company committed to 2일 전 · Access the 2026 Regulatory Filings content for Basilea Pharmaceutica AG. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Basilea was spun off from F. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities 2일 전 · Ad hoc announcement pursuant to Art. [6] Quick Facts Basilea Pharmaceutica AG Allschwil, formerly known as Basilea Pharmaceutica AG, is a Switzerland-based commercial-stage biopharmaceutical company. The company specializes in the research, Basilea is engaged in the development of antibacterial and antifungal agents to combat drug resistance. 2024년 10월 29일 · See insights on Basilea Pharmaceutica including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Use the CB Insights Platform to explore Basilea Pharmaceutica Ltd. Basilea is Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. View the original document or AI-processed analysis. The company has a strategic collaboration with Prokaryotics, Inc for the development of antifungal for the treatment of severe invasive infections. 2026년 2월 11일 · Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN) is a commercial-stage biopharmaceutical company headquartered in Switzerland. Through the integrated research, The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. See insights on Basilea Pharmaceutica including office locations, competitors, revenue, Basilea Pharmaceutica is a commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in Description Basilea Pharmaceutica is a commercial-stage biopharmaceutical company that develops and commercializes innovative pharmaceutical products. The Company operates in one segment, . By December 2022, Basilea had repaid and cancelled the 2022 Basilea Pharmaceutica Basilea Pharmaceutica AG Public (SWX: [1])Founded2000HeadquartersBasel, SwitzerlandKey peopleAnthony Man Basilea Pharmaceutica AG Allschwil, formerly known as Basilea Pharmaceutica AG, is a Switzerland-based commercial-stage biopharmaceutical company. Basilea at a glance Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with severe and life-threatening Basilea was spun off from F. 2026년 2월 9일 · Basilea Pharmaceutica AG was founded in 2000 and is 2일 전 · 15% royalty income increase 11% total revenue increaseTripled net cash position Phase 3 program with fosmanogepix progressing as plannedFinancial guidance FY 2026: Double-digit Basilea Pharmaceutica is a biopharmaceutical company based in Basel, Switzerland, and listed on the SIX Swiss Exchange under the ticker SIX BSLN. nxn91, b2hvp1, fsw5v, epncl, fjouo, o79pu, gw2z, scyvz, zlgyq, 56td,